Successful Anti-PD-1 Cancer Immunotherapy Requires T Cell-Dendritic Cell Crosstalk Involving the Cytokines IFN-γ and IL-12

Christopher Garris(Harvard University), Sean P. Arlauckas(Massachusetts General Hospital), Rainer H. Köhler(Massachusetts General Hospital), Marcel P. Trefny(University Hospital of Basel), Seth B. Garren(Massachusetts General Hospital), Cécile Piot(Massachusetts General Hospital), Camilla Engblom(Massachusetts General Hospital), Christina Pfirschke(Massachusetts General Hospital), Marie Siwicki(Harvard University), Jeremy Gungabeesoon(Massachusetts General Hospital), Gordon J. Freeman(Harvard University), Sarah Warren(Nanostring Technologies (United States)), SuFey Ong(Nanostring Technologies (United States)), Erica Browning, Chris Twitty, Robert H. Pierce, Mai H. Le, Alain P. Algazi(University of California San Francisco Medical Center), Adil Daud(University of California San Francisco Medical Center), Sara I. Pai(Harvard University), Alfred Zippelius(University Hospital of Basel), Ralph Weissleder(Harvard University), Mikaël J. Pittet(Massachusetts General Hospital)
Immunity
December 1, 2018
Cited by 927Open Access
Full Text

Abstract


Related Papers

No related papers found

Powered by citation graph analysis